Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0451641 (
urolithiasis
)
3,973
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Alkaptonuria is a rare autosomal recessive disorder of
tyrosine
metabolism. Deficiency of homogentisate 1,2 dioxygenase results in accumulation of oxidized homogentisic acid in the connective tissues of the skin, eyes and ears, musculoskeletal system, and cardiac valves, and in
urolithiasis
. Excretion of excessive homogentisic acid in urine causes dark-colored urine on exposure to air. We present a case of alkaptonuria with multiple system involvement, who presented with lower urinary tract symptoms secondary to vesical and prostatic calculi.
...
PMID:Alkaptonuric Ochronosis. 2781 2
Urolithiasis
is a common urological disease with a high morbidity and recurrence rate, of which calcium oxalate (CaOx) is the most common type of stone that underlies the disease. However, the potential metabolic mechanisms of CaOx
urolithiasis
remain unclear. The present study aimed to seek potential biomarkers and metabolic mechanisms of CaOx
urolithiasis
in adults. Urine samples were collected from 36 healthy individuals and 36 patients diagnosed with bilateral upper-urinary-tract stones. All of the stones were composed of CaOx. Ultra-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS) was used to perform a metabolic fingerprinting analysis. Principal component analysis (PCA) and orthogonal partial least-squares determinant analysis (OPLS-DA) were carried out to analyze the multivariate data. There were 18 differential metabolites identified, which mainly involved caffeine, phenylalanine, galactose, and
tyrosine
metabolism. The results revealed potential urinary biomarkers, via metabolic fingerprinting of adults with CaOx
urolithiasis
, which may help to improve future metabolic evaluation of
urolithiasis
. The elucidated metabolic pathways may have potential applications as novel treatment targets of CaOx
urolithiasis
. Additionally, our study suggests that the UPLC-Q-TOF/MS platform may offer new insights into the pathobiology of
urolithiasis
.
...
PMID:Identification of urine biomarkers for calcium-oxalate urolithiasis in adults based on UPLC-Q-TOF/MS. 3125 1